Edition:
United Kingdom

GlycoMimetics Inc (GLYC.OQ)

GLYC.OQ on NASDAQ Stock Exchange Global Market

3.37USD
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
$3.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
143,930
52-wk High
$16.32
52-wk Low
$2.65

About

GlycoMimetics, Inc. is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs. The Company operates through the identification and development of glycomimetic compounds segment. The Company is developing its lead drug candidate, GMI-1070 (Rivipansel), for the treatment... (more)

Overall

Beta: 2.35
Market Cap(Mil.): $389.49
Shares Outstanding(Mil.): 43.18
Dividend: --
Yield (%): --

Financials

  GLYC.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -1.18 -- --
ROI: -23.38 7.52 12.69
ROE: -23.60 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates